CURE

FDA Approves Subcutaneous Keytruda in Adult and Pediatric Solid Tumors

The FDA has granted approval to subcutaneous Keytruda for use in adults and pediatric patients with a solid tumor.
Managed Healthcare Executive

FDA Approves First Subcutaneous Version of Keytruda for Adults With Most Solid Tumors

Merck's Keytruda Qlex offers a groundbreaking subcutaneous cancer treatment, enhancing patient convenience with faster ...
SurvivorNet on MSN

FDA Approves New Subcutaneous (Under-the-Skin) Option for Keytruda: What It Means for Cancer Patients

The U.S. Food and Drug Administration (FDA) has approved the subcutaneous form of Keytruda for a new 'Under-the-Skin' Option for patients. The subcutaneous form of Keytruda showed to deliver the same ...
Medscape

FDA OKs Subcutaneous Atezolizumab Formulation for Multiple Cancer Indications

The US Food and Drug Administration (FDA) has approved atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza, Genentech, Inc.) as a subcutaneous injection in adults, covering all approved indications ...
Cure Today

FDA Approves Subcutaneous Tecentriq Formulation

Tecentriq Hybreza, a subcutaneous delivery of the drug, was approved for certain types of sarcoma, in addition to lung, skin and liver cancers. The Food and Drug Administration (FDA) approved ...
The Chosun Ilbo on MSN

Keytruda Subcutaneous Formulation Receives FDA Approval

The first immune checkpoint inhibitor that can be administered via a subcutaneous injection in just 1 to 2 minutes has ...